In most markets, sunscreen is a cosmetic. In the European Union, sunscreens are regulated under EU Regulation 1223/2009 as cosmetic products, requiring CPNP notification and a Cosmetic Product Safety Report. In the United States, the classification is fundamentally different. Any product that claims to prevent sunburn, protect against UV radiation, or provide a specific SPF value is classified as a drug under the Federal Food, Drug, and Cosmetic Act. That single classification difference means foreign manufacturers of SPF products face FDA drug compliance requirements — drug establishment registration, drug listing, a Drug Facts panel formatted to FDA specifications, and NDC numbers — rather than the cosmetic compliance framework that applies in their home market. A sunscreen product treated as a cosmetic and shipped to the US will be refused at the border.
Why the FDA classifies sunscreens as OTC drugs
The FD&C Act defines a drug as any article intended to affect the structure or any function of the body, or intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. Sunscreens prevent sunburn — classified by the FDA as a disease — and reduce the risk of early skin aging and skin cancer. These are disease prevention claims that bring a product into the drug definition under US law. The FDA regulates most sunscreens under the OTC drug monograph system: the OTC Sunscreen Monograph specifies which active UV filters are permitted (including zinc oxide and titanium dioxide), at what concentrations, what SPF testing methodology applies, and what claims the Drug Facts panel must include. Products using active ingredients not listed as Category I (Generally Recognized as Safe and Effective) under the current OTC monograph proposal cannot be legally marketed in the US without an approved New Drug Application.
Drug establishment registration requirements for sunscreen manufacturers
Any foreign facility that manufactures a sunscreen or SPF product for US distribution must register as a drug establishment under 21 CFR Part 207, using the FDA's Drug Registration and Listing System (DRLS). The drug establishment registration is separate from and in addition to any food or cosmetic registration the facility may hold. The registration must identify the facility type, the drug product categories manufactured at the site, and the US Agent. It must be renewed annually during the October–December re-registration window. Missing the annual window means the registration lapses — and a lapsed drug establishment registration means the facility's products cannot legally enter the US market. OMUFA facility fees apply to OTC monograph drug manufacturing facilities: the FDA assesses an annual fee on each registered facility, invoiced through the US Agent.
The Drug Facts panel and what it requires for sunscreens
Every OTC sunscreen sold in the United States must display a Drug Facts panel formatted under 21 CFR 201.66. The panel must include Active Ingredients (UV filters with their SPF or UVA/UVB designations and concentrations), Uses (specific claim language such as helps prevent sunburn), Warnings (including keep out of reach of children, stop use and ask a doctor if language, water resistance claims if applicable, and the skin cancer/skin aging alert for products above SPF 15), Directions (including reapplication intervals), and Inactive Ingredients. The panel must appear in a labeled box, use a minimum 6-point font, and present information in the FDA-mandated sequence. An SPF product with no Drug Facts panel, or with a panel that substitutes a cosmetic-style ingredient list and claims, is misbranded as a matter of law — regardless of whether the product itself is safe and effective.
SPF claims in cosmetic combination products
Foreign cosmetic brands frequently add SPF claims to moisturizers, foundations, lip balms, and body lotions as marketing differentiation for the US market. The regulatory consequence is that adding an SPF or UV protection claim to any cosmetic product converts that product into an OTC drug for US regulatory purposes. A moisturizer is a cosmetic and falls under MoCRA. A moisturizer with SPF 30 is an OTC drug and requires drug establishment registration, drug listing, an NDC number, and a Drug Facts panel. The same logic applies to lip balm with SPF, tinted sunscreen, BB cream with SPF, and any other product that combines cosmetic function with a UV protection claim. Foreign cosmetic brands that add SPF values to US-market labels without completing drug establishment registration create a compliance violation affecting every such product in their US portfolio.
How FDABridge handles sunscreen and SPF product registration
FDABridge manages drug establishment registration, drug listing, NDC number coordination, and Drug Facts panel review for foreign manufacturers of sunscreen and SPF products. We advise on active ingredient eligibility under the current OTC monograph proposal, identify which products require a separate NDA rather than monograph marketing, and handle the annual re-registration cycle. Visit fdabridge.com/drug for our drug registration services or fdabridge.com/apply/drug to start the filing process.
Need help with drug registration?
See how our drug quote flow works for establishment registration, NDC Labeler Code, and product listing support.